The mission of NNECOS is to promote the highest quality care for patients with cancer and blood disorders in our region through professional networking, education, and scientific research, as well as patient advocacy and public policy.

NNECOS News!

 

NNECOS NAHPAC Seeking Members

Leadership Opportunity for Allied Health Professionals

The NNECOS NAHPAC is seeking new members for 2022! If you are a pharmacist, advanced practice provider, or another allied health professional who would be interested in serving on this important NNECOS committee, we'd love to hear from you! Simply submit a letter of interest via email to laubrey@nnecos.org by 12:00pm on Monday, July 11th.

THANK YOU, FELLOW BOARD LIAISONS

 

Join us in thanking outgoing NNECOS Fellow Board Liaisons, Dr. Odeth Barrett-Campbell, and Dr. Kara Landry, for their service to the board. Dr. Barrett-Campbell has served as a fellow liaison for the past two years, and will be practicing general hematology/oncology in West Virginia this fall. Dr. Landry has served as a fellow liaision for the past year, and will be continuing her career as an attending at the UVM medical center, specializing in cancer genetics and breast oncology. We wish them both well in this next phase of their careers!

ANNUAL MEETING UPDATE

Registration Opens Later This Month!

De-Escalation in Head and Neck Cancer
 
Session Spotlight - Using Nutritional Psychiatry

We're looking forward to reconnecting in person for our 2022 NNECOS Annual Meeting, October 28-29, 2022 at the Omni Mt. Washington Resort! The Annual Meeting Planning Task Force has designed a creative and engaging meeting, organizing topics into a series of thematic symposiums, with plenty of time to network and reconnect!

Friday morning begins with our annual Palliative Care Symposium, which will address Pain Management, The Transformative Power of Hope, and Hot Topics in Palliative Care Research.

Friday afternoon, we will delve into "The New Normal: Living with COVID", which will feature a lecture from Dr. Uma Naido, Director of Nutritional & Lifestyle Psychiatry at Massachusetts General Hospital,  "Using Nutritional Psychiatry - Tips and Tools for Provider Recovery from COVID", as well as presentations on healthy living, and stress first aid, plus an engaging panel discussion. We'll round out the afternoon by examining rural health and how it's been impacted by COVID.

Friday evening, it's all about abstracts, beginning with our annual cocktail reception and poster session, after which, we'll convene in the dining room for the return of our attendee dinner, and podium presentations of the top abstracts.

On Saturday, our focus will turn to "Optimizing Supportive Care in Complicated Patients: Getting Them Through the Gauntlet", bringing together an interdisciplinary team for an engaging, case-based discussion, followed by the Steven M. Grunberg, MD Memorial Keynote, presented by Dr. Sue Yom from the University of California San Francisco, De-Escalation in Head and Neck Cancer, in the Era of Personalized Medicine. For our final session of the afternoon, we'll have an update on COVID for Patients with Cancer. Registration is expected to open later this month, so save the dates!

REMINDER: Accommodation requests will be processed at the time of meeting registration - directly through NNECOS - please DO NOT contact the Mt. Washington to reserve your room! We anticipate registration will open in mid to late July. Check back at nnecos.org/2022-annual for updates. 


NNECOS Lunchtime Best Oncology Practice Series

Next up in the NNECOS Lunchtime Best Oncology Practice Series, Monica Fawzy Bryant, Esq, presents "Navigating Cancer-Related Legal Issues to Help Patients Avoid Financial Toxicity." Join us Thursday, July 21st at 12:00pm.

Cancer is expensive. But there are ways to minimize the financial impact of a cancer diagnosis and treatment. Monica Bryant, a cancer rights attorney, and COO of Triage Cancer, will provide information about health insurance options and navigation, employment rights, and disability insurance. Attendees will walk away with practical tools to help their patients avoid financial toxicity.

Set a recurring appointment on your calendar for the third Thursday of each month, and plan to share your lunchtime with NNECOS. View the current schedule and sign-up for the NNECOS Lunchtime Best Oncology Practice Series at nnecos.org/lunchtime.

RECORDING AVAILABLE!

I'm Your Nurse Lunchtime Webinar Recording Available

If you missed Dr. Kecia Boyd's presentation, "I'm not the housekeeper, I'm your nurse", we've got great news for you! For a limited time, you can view the recording of this informative presentation on the NNECOS website! Learn about Dr. Boyd's research and gain a deeper understanding of the issues facing African-American registered nurses in the workplace. Dr. Boyd also invites you to check out the informative video about Allyship, to learn how we can all take meaningful action. 

 

NNECOS Patient Assistance Presentation Series

The second in the series of 2022 NNECOS Patient Assistance Presentation Series continues Thursday, August 4th at 12:00pm.

Previously offered in conjunction with the NNECOS Spring Meeting, this virtual series provides an opportunity for invited corporate member companies to showcase their patient assistance programs to financial advocates, social workers, navigators, and other interested members of the care team in the NNECOS community, with lunch provided by NNECOS. Register today at nnecos.org/reimbursement

Congratulations, Dr. Alissa Thomas!

Congratulations to Dr. Alissa Thomas, Associate Professor of Neurological Sciences at the University of Vermont on being awarded a NNECOS Research Grant for her project, "Venous Thromboembolism Prevention in Outpatients with Glioma (VTE-POG)". This two-year project will build on data from a previous 10-patient pilot study, with the goal of demonstrating the safety of apixaban for VTE prevention. http://nnecos.org/research/

 
Thank you NAHPAC Members

Join us in thanking outgoing Nursing and Allied Health Professional Advisory Committee members, Emma Dann, DNP, Amy Litterini, DPT, and Matt Marston, PharmD. Their combined years of service and dedication to strengthening the interdisciplinary care of patients with cancer in our region have made a tremendous impact.

Cancer Community Support - NNECOS is your partner in supporting patients with cancer in Northern New England

In response to the ongoing pandemic, the NNECOS Board of Directors, through the NNECOS Philanthropy Task Force, is pleased to continue to support two emergency need programs designed to bring help to patients with cancer who are facing extra need during this global pandemic. nnecos.org/ccsc

SPACE IS STILL AVAILABLE!

OCN REVIEW COURSE

SEPTEMBER 9-10, 2022

CONCORD, NH

NNECOS OCN Review Course - Save the Date

Achieving the professional specialty certification of Oncology Certified Nurse (OCN) is a validation of a nurse's clinical experience and knowledge, a professional accomplishment recognized by patients and peers. Our review course is an intensive training devoted to oncology nurses. Featuring an all-new curriculum to reflect the updated review book and exam blueprints, our course also includes a virtual practice test question night on September 15th, which helps contribute to the success of past participants in passing the exam. Participants who pass the OCN exam are also eligible to receive a congratulatory gift card!

Register Today!

Congratulations, Dr. Meehan, on your Excellence in Teaching Award!

Congratulations, Dr. Meehan, Excellence in Teaching Award

 NNECOS Board Member, Dr. Ken Meehan, center, pictured with Fellow Board Liaison Dr. Odeth Barrett-Campbell and Fellow Dr. Lukas Emery. 

ASCO in Action

ASCO Member Survey on Prior Authorization


The Association for Clinical Oncology’s (ASCO) member survey on the impact of prior authorization on cancer care has launched. This research will yield important findings on how prior authorization is affecting cancer patients and oncology practices.

Ranked as the top policy and advocacy concern in the 2022 State Affiliate survey, prior authorization practices are delaying patient access to appropriate cancer care. 

Take the survey at: 

https://www.surveymonkey.com/r/ascopaq2022vol

Medicare Innovation Center Announces New Oncology Payment Model

On June 27, the Centers for Medicare & Medicaid Services (CMS), through its Center for Medicare & Medicaid Innovation (CMMI), announced a new, voluntary oncology payment model—the Enhancing Oncology Model (EOM).

EOM is a 5-year voluntary payment model set to begin on July 1, 2023. Under EOM, participating oncology practices will take on financial and performance accountability for episodes of care surrounding systemic chemotherapy administration to patients with seven common cancer types: breast cancer, chronic leukemia, small intestine/colorectal cancer, lung cancer, lymphoma, multiple myeloma, and prostate cancer. EOM participants will be responsible for the total cost of care during a 6-month episode and will elect to participate in one of two two-sided financial risk arrangements. Read more on ASCO in Action.

Register for the July ASCO Practice Leadership Call

Mark your calendar! The American Society of Clinical Oncology (ASCO) is holding its next Practice Leadership Call on Thursday, July 21 at 4:00 – 5:00 PM Eastern. CMS recently announced its new Enhancing Oncology Model, to begin in July 2023. This new model builds off lessons from OCM and feedback from the oncology community, including but not limited to: OCM participants, patient advocacy groups, oncology professional associations, and others. During the call, CMS representatives will provide a presentation about the new model and what it may mean for your practice. Register today!

 

Sequestration Cuts Return to 2% on July 1, 2022

On December 10, 2021, President Biden signed the “Protecting Medicare and American Farmers from Sequester Cuts Act,” which phased in the Medicare sequester cuts that had been paused during the COVID-19 Public Health Emergency (PHE), starting April 1, 2022. From April 1 through June 30, 2022, the cut is 1%. The cut will return to 2% on July 1, 2022. Prior to the bill’s passage, the American Medical Association’s House of Delegates approved an Association for Clinical Oncology (ASCO)-backed resolution opposing Medicare sequestration cuts in November 2021. ASCO also urged Congress to prevent these cuts, highlighting without congressional intervention, oncology care providers were facing a combination of cuts to Medicare reimbursement in 2022 due to the expiration of sequestration and pandemic relief, as well as the implementation of budget neutrality mandates. Read more on ASCO in Action.

ASCO Statement on Supreme Court Decision in Dobbs v. Jackson - Women’s Health

The American Society of Clinical Oncology (ASCO) is committed to the delivery of medically appropriate, equitable, evidence-based cancer care. For patients of child-bearing age, a cancer diagnosis raises medical considerations around pregnancy and fertility preservation. Every patient should have the ability to pursue, in partnership with their oncologist, all treatment options that offer the best chance of a successful outcome for their cancer.

Unfortunately, the implementation of laws based on the Dobbs decision could limit these options. ASCO is working to help our members navigate this new situation and preserve their patients’ access to the highest quality care by providing evidence-based clinical guidance, including for fertility preservation, and by advocating for access to all the components of high-quality care.

Industry-Related Resources

The NNECOS website hosts a variety of collated resources related to cancer medications, including our NNECOS FDA Approvals page  - a chronological, collated resource for the latest approval and indication information. For those times when you're looking for a specific manufacturer or drug-specific reimbursement contact, check out our Regional Reimbursement Contacts page. For your convenience, we also provide information for you to stay up-to-date with Package/Label and Code updates.

FDA Approvals

  • June 22nd - FDA grants accelerated approval to dabrafenib in combination with trametinib for unresectable or metastatic solid tumors with BRAF V600E mutation



Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software